The association between HIV and antituberculosis drug resistance

European Respiratory Journal

Volumn 32, Issue 3, 2008, Pages 718-725

  French, C E ^a   Glynn, J R ^b   Kruijshaar, M E ^a   Ditah, I C ^c   Delpech, V ^a   Abubakar, I ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

Antituberculosis drug resistance; England and Wales; HIV; Tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; TUBERCULOSIS; UNITED KINGDOM; AIDS RELATED COMPLEX; HEALTH SURVEY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MIDDLE AGED; MULTIDRUG RESISTANT TUBERCULOSIS; PREVALENCE;

ADOLESCENT; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ENGLAND; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PREVALENCE; TUBERCULOSIS, MULTIDRUG-RESISTANT; WALES;

EID: 58149390050     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00022308     Document Type: Article

References (30)

1. Health Protection Agency. Focus on Tuberculosis: Annual Surveillance Report 2006 - England, Wales and Northern Ireland. London, Health Protection Agency Centre for Infections, 2006. Available from: www.hpa.org.uk/web/ HPAweb&HPAwebStandard/HPAweb-C/1195733800680
2. Ahmed AB, Abubakar I, Delpech V, et al. The growing impact of HIV infection on the epidemiology of tuberculosis in England and Wales: 1999-2003. Thorax 2007; 62: 672-676.
3. Goble M, Iseman MD, Madsen LA, Waite D, Ackerson L, Horsburgh CR. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. N Engl J Med 1993; 328: 527-532.
4. Quy HT, Cobelens FGJ, Lan NTN, Buu TN, Lambregts CSB, Borgdorff MW. Treatment outcomes by drug resistance and HIV status among tuberculosis patients in Ho Chi Minh City, Vietnam. Int J Tuberc Lung Dis 2006; 10: 45-51.
5. Aziz MA, Wright A, Laszlo A, et al. Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysis. Lancet 2006; 368: 2142-2154.
6. Lienhardt C, Rodrigues LC. Estimation of the impact of the human immunodeficiency virus infection on tuberculosis: tuberculosis risks re-visited? Int J Tuberc Lung Dis 1997; 1: 196-204.
7. Pearson ML, Jereb JA, Frieden TR, et al. Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis. A risk to patients and health care workers. Ann Intern Med 1992; 117: 191-196.
8. Telenti A. Genetics and pulmonary medicine. 5. Genetics of drug resistant tuberculosis. Thorax 1998; 53: 793-797.
9. Burman WJ, Jones BE. Treatment of HIV-related tuberculosis in the era of effective antiretroviral therapy. Am J Respir Crit Care Med 2001; 164: 7-12.
10. Control and prevention of tuberculosis in the United Kingdom: Code of Practice 2000. Joint Tuberculosis Committee of the British Thoracic Society. Thorax 2000; 55: 887-901.
11. National Institute for Health and Clinical Excellence. Tuberculosis. Clinical Diagnosis and Management of Tuberculosis, and Measures for its Prevention and Control. London, National Institute for Health and Clinical Excellence, 2006. Available from: www.nice.org.uk/guidance/index.jsp?action= byID&o=10980
12. Centers for Disease Control (CDC). Transmission of multidrug-resistant tuberculosis among immunocompromised persons in a correctional system - New York, 1991. MMWR Morb Mortal Wkly Rep 1992; 41: 507-509.
13. Edlin BR, Tokars JI, Grieco MH, et al. An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med 1992; 326: 1514-1521.
14. Faustini A, Hall AJ, Perucci CA. Risk factors for multidrug resistant tuberculosis in Europe: a systematic review. Thorax 2006; 61: 158-163.
15. Robert J, Trystram D, Truffot-Pernot C, Jarlier V. Multidrug-resistant tuberculosis: eight years of surveillance in France. Eur Respir J 2003; 22: 833-837.
16. Haar CH, Cobelens FGJ, Kalisvaart NA, van der Have JJ, van Gerven PJHJ, van Soolingen D. Tuberculosis drug resistance and HIV infection, the Netherlands. Emerg Infect Dis 2007; 13: 776-778.
17. Ferrara G, Richeldi L, Bugiani M, et al. Management of multidrug-resistant tuberculosis in Italy. Int J Tuberc Lung Dis 2005; 9: 507-513.
18. World Health Organization/International Union Against Tuberculosis and Lung Disease. Anti-tuberculosis Drug Resistance in the World: the WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance, 2002-2007. Report no. 4. WHO/HTM/TB/2008.394. Geneva, World Health Organization, 2008.
19. Anastasis D, Pillai G, Rambiritch V, Abdool Karim SS. A retrospective study of human immunodeficiency virus infection and drug-resistant tuberculosis in Durban, South Africa. Int J Tuberc Lung Dis 1997; 1: 220-224.
20. Kenyon TA, Mwasekaga MJ, Huebner R, Rumisha D, Binkin N, Maganu E. Low levels of drug resistance amidst rapidly increasing tuberculosis and human immunodeficiency virus co-epidemics in Botswana. Int J Tuberc Lung Dis 1999; 3: 4-11.
21. Warndorff DK, Yates M, Ngwira B, et al. Trends in antituberculosis drug resistance in Karonga District, Malawi, 1986-1998. Int J Tuberc Lung Dis 2000; 4: 752-757.
22. Singh JA, Upshur R, Padayatchi N. XDR-TB in South Africa: no time for denial or complacency. PLoS Med 2007; 4: e50.
23. Irish C, Herbert J, Bennett D, et al. Database study of antibiotic resistant tuberculosis in the United Kingdom, 1994-6. BMJ 1999; 318: 497-498.
24. Djuretic T, Herbert J, Drobniewski F, et al. Antibiotic resistant tuberculosis in the United Kingdom: 1993-1999. Thorax 2002; 57: 477-482.
25. Conaty SJ, Hayward AC, Story A, Glynn JR, Drobniewski FA, Watson JM. Explaining risk factors for drug-resistant tuberculosis in England and Wales: contribution of primary and secondary drug resistance. Epidemiol Infect 2004; 132: 1099-1108.
26. Mortimer JY, Salathiel JA. "Soundex" codes of surnames provide confidentiality and accuracy in a national HIV database. Commun Dis Rep CDR Rev 1995; 5: R183-R186.
27. Health Protection Agency. The UK Mycobacterial Surveillance Network Report 1994-2003: 10 years of MycobNet. London, Tuberculosis Section, Health Protection Agency, Centre for Infections, 2005. Available from: www.hpa.org.uk/web/HPAweb&HPAwebStandard/HPAweb-C/1195733800680
28. Ruddy MC, Davies AP, Yates MD, et al. Outbreak of isoniazid resistant tuberculosis in north London. Thorax 2004; 59: 279-285.
29. Story A, Murad S, Verheyen M, Roberts W, Hayward AC. Tuberculosis in London: the importance of homelessness, problem drug use and prison. Thorax 2007; 62: 667-671.
30. The UK Collaborative Group for HIV and STI Surveillance. Testing times. HIV and other Sexually Transmitted Infections in the United Kingdom: 2007. London, Health Protection Agency, Centre for Infections, 2007. Available from: www.hpa.org.uk/web/HPAweb&HPAwebStandard/HPAweb-C/1204100473908